| 1 |
31783010 | Overcoming Taxol-resistance in A549 cells: A comprehensive strategy of targeting P-gp transporter, AKT/ERK pathways, and cytochrome P450 enzyme CYP1B1 by 4-hydroxyemodin. | 2020 Jan |
15 |
| 2 |
32203789 | Carvedilol serves as a novel CYP1B1 inhibitor, a systematic drug repurposing approach through structure-based virtual screening and experimental verification. | 2020 May 1 |
2 |
| 3 |
25516145 | CYP1B1 enhances the resistance of epithelial ovarian cancer cells to paclitaxel in vivo and in vitro. | 2015 Feb |
5 |
| 4 |
18597657 | Prediction of paclitaxel resistance in breast cancer: is CYP1B1*3 a new factor of influence? | 2008 Jul |
4 |
| 5 |
17224914 | Pharmacogenetic analysis of paclitaxel transport and metabolism genes in breast cancer. | 2007 Oct |
2 |
| 6 |
11160641 | Human CYP1B1 and anticancer agent metabolism: mechanism for tumor-specific drug inactivation? | 2001 Feb |
1 |